|
|
Volumn 13, Issue 5, 2014, Pages 679-680
|
|
Skp2: A dream target in the coming age of cancer therapy
a
b,c
b,c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
F BOX PROTEIN;
S PHASE KINASE ASSOCIATED PROTEIN 2;
ANTINEOPLASTIC AGENT;
S PHASE KINASE ASSOCIATED PROTEIN;
UBIQUITIN PROTEIN LIGASE;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
BINDING AFFINITY;
CANCER CHEMOTHERAPY;
CANCER STEM CELL;
CANCER THERAPY;
CARCINOGENESIS;
CELL AGING;
CELL CYCLE PROGRESSION;
CELL GROWTH;
CHEMICAL MODIFICATION;
COMPLEX FORMATION;
EDITORIAL;
GLIOBLASTOMA;
HIGH THROUGHPUT SCREENING;
HUMAN;
PROSTATE CANCER;
PROTEIN EXPRESSION;
PROTEIN PROTEIN INTERACTION;
PROTEIN TARGETING;
STRUCTURE ACTIVITY RELATION;
TREATMENT FAILURE;
TUMOR GROWTH;
UBIQUITINATION;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
DRUG DEVELOPMENT;
DRUG EFFECTS;
ENZYMOLOGY;
NEOPLASM;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUG DISCOVERY;
HUMANS;
NEOPLASMS;
NEOPLASTIC STEM CELLS;
S-PHASE KINASE-ASSOCIATED PROTEINS;
UBIQUITIN-PROTEIN LIGASES;
|
|
EID: 84897995252
PISSN: 15384101
EISSN: 15514005
Source Type: Journal
DOI: 10.4161/cc.27853 Document Type: Editorial |
|
Times cited : (42)
|
|
References (8)
|
